Arrhythmogenic Cardiomyopathy with Woolly Hair and Keratoderma

Arrhythmogenic cardiomyopathy with woolly hair and keratoderma is a rare, inherited heart-and-skin condition. Babies typically have woolly, tightly curled hair from birth. During early childhood, the skin of the palms and soles becomes thick and hard (palmoplantar keratoderma). Over time, the heart muscle becomes weak and scarred, especially in the right or left ventricle. That scarring can disrupt the heart’s electrical signals, causing palpitations, fainting, dangerous heart rhythms, heart failure, and—without treatment—sudden cardiac death. The condition is caused by mistakes (variants) in the “glue” proteins that hold heart and skin cells together (desmosomes), most commonly plakoglobin (JUP) and desmoplakin (DSP). When these proteins fail, cells detach under mechanical stress (like exercise), and the body replaces damaged heart muscle with fat and fibrous tissue, which does not conduct electricity or contract normally. Orpha+3PMC+3PMC+3

Arrhythmogenic cardiomyopathy with woolly hair and keratoderma is a rare inherited condition that links the heart and the skin. Children (or sometimes teens and young adults) have very curly “woolly” hair from birth, thick skin on the palms and soles (palmoplantar keratoderma), and a weak heart muscle that can develop dangerous heart rhythms. The heart problem belongs to the “arrhythmogenic cardiomyopathy” (ACM) family—muscle cells break their normal “glue” connections (desmosomes), some cells die, and are replaced by fatty and fibrous tissue, which triggers abnormal beats and can lead to heart failure or sudden cardiac death without proper care. The skin signs often appear years before the heart signs, so they are important early clues for families and doctors. PMC+2JACC+2

Other names

• Naxos disease (ARVC with woolly hair and diffuse palmoplantar keratoderma; usually right-ventricle–dominant). Orpha

• Carvajal syndrome (left-ventricle–dominant dilated cardiomyopathy with woolly hair and striate keratoderma; classically due to DSP variants). PMC

• Cardiocutaneous syndromes / Keratoderma with woolly hair, types I–III (Type I “Naxos type” with ARVC; Type II “Carvajal type” with left-ventricular DCM; Type III milder hair/skin with ARVC). MedlinePlus

• Arrhythmogenic cardiomyopathy (ACM), syndromic forms (broader umbrella that includes right-, left-, and biventricular phenotypes, sometimes with skin/hair features). PubMed

Types

1. Naxos type (right-dominant)
   This form combines arrhythmogenic right ventricular cardiomyopathy (ARVC) with woolly hair and diffuse thickening of the palms and soles. Arrhythmias often begin in adolescence or young adulthood, sometimes triggered by intense exercise. PMC+1
2. Carvajal type (left-dominant)
   This form tends to affect the left ventricle more, looking like a dilated cardiomyopathy on imaging. The skin findings are typically striate (linear) keratoderma rather than fully diffuse. Malignant ventricular arrhythmias can occur early. PMC
3. Biventricular arrhythmogenic cardiomyopathy (overlap)
   Some patients show scarring and rhythm problems in both ventricles. Gene testing and MRI help sort this out, because management may be more aggressive when both sides are involved. PubMed

Why these categories matter: right- vs left-dominant disease can change how we screen family members, what we look for on ECG/MRI, and how we assess arrhythmic risk (including whether to consider an implantable defibrillator). Heart Rhythm Journal

Causes

In this condition, “causes” are mostly genetic variants that weaken desmosomes. A few modifiers can make disease start sooner or get worse. Each item below explains “what it is” and “why it matters.”

1. JUP (plakoglobin) loss-of-function variants – The classic cause of Naxos disease; disrupts cell-to-cell adhesion in heart and skin so tissue breaks down with stress. ScienceDirect

2. DSP (desmoplakin) truncating variants – Hallmark of Carvajal syndrome; strongly linked to left-dominant or biventricular disease plus keratoderma and woolly hair. PMC

3. Autosomal recessive inheritance – Many cardio-cutaneous families inherit two non-working copies (one from each parent), explaining early and severe disease. PMC

4. Autosomal dominant DSP/JUP variants – Less common but possible; some families show dominant transmission with variable skin involvement. PMC

5. Desmosomal stress from endurance exercise – High-intensity, long-duration exercise accelerates damage in desmosome-deficient hearts, worsening scarring and arrhythmias. (Guidelines advise activity restriction.) Heart Rhythm Journal

6. Modifier variants in other desmosomal genes (PKP2, DSG2, DSC2) – These usually cause “isolated” ARVC, but can modify severity in cardio-cutaneous forms. AHA Journals

7. TMEM43 p.S358L and related genes (non-cutaneous ACM) – Do not typically cause keratoderma, but illustrate the same pathway: faulty mechanical coupling → scarring/arrhythmias. PubMed

8. Inflammation (“hot-phase” myocarditis-like episodes) – In genetically primed hearts, inflammation can trigger scar expansion and new arrhythmias. PMC

9. Male sex and adolescent growth spurt – Mechanical load and hormones may unmask disease during teen years in genetically affected youth. Heart Rhythm Journal

10. Early childhood skin stress – Keratoderma typically appears when toddlers start using hands/feet more, revealing skin fragility from desmosome weakness. AHA Journals

11. Fever/systemic illness – Increases metabolic and electrical stress and can precipitate arrhythmias in scarred ventricles. (General ACM observation.) Heart Rhythm Journal

12. Electrolyte disturbances (low potassium/magnesium) – Make ventricular arrhythmias more likely when the substrate exists. (Guideline principle.) Heart Rhythm Journal

13. Stimulants (e.g., certain decongestants/energy drinks) – Can raise adrenergic drive and provoke arrhythmias in vulnerable hearts. Heart Rhythm Journal

14. Pregnancy/post-partum hemodynamic stress – Increased volume and heart work may aggravate LV-dominant disease (Carvajal). Heart Rhythm Journal

15. Untreated high blood pressure – Adds wall stress, potentially worsening LV remodeling in DSP-related disease. Heart Rhythm Journal

16. Viral myocarditis superimposed on ACM – Infection-triggered injury on top of desmosomal weakness can accelerate scar. PMC

17. Smoking – Increases arrhythmic risk and worsens vascular/oxygen supply; avoidance is part of standard ACM advice. Heart Rhythm Journal

18. Family clustering/consanguinity – Raises the chance of inheriting two bad copies (AR). Orpha

19. Incomplete penetrance/variable expressivity – Same variant, different severity; explains why some relatives have hair/skin only, others have dangerous arrhythmias. PMC

20. Immunohistochemical loss of junctional proteins (pathway) – Not a “cause” by itself, but a measurable sign of the desmosomal failure driving the heart and skin features. PMC

Symptoms

1. Woolly, tightly curled hair from birth – Often the first clue; hair texture is markedly different from family members. PMC

2. Thick, hard skin on palms/soles (keratoderma) – Appears in infancy/early childhood; may crack and hurt with activity. AHA Journals

3. Palpitations – A sense of the heart racing or skipping beats due to ventricular ectopy or tachycardia. Heart Rhythm Journal

4. Fainting (syncope) – Especially during exertion or stress; a red-flag for dangerous arrhythmias. Heart Rhythm Journal

5. Exercise intolerance – Getting tired easily, breathless, or light-headed with activity. Heart Rhythm Journal

6. Chest discomfort – Sometimes during “hot-phase” inflammation episodes that mimic myocarditis. PMC

7. Shortness of breath – From reduced pump function or rapid rhythms. Heart Rhythm Journal

8. Swelling of legs/ankles – A sign of advancing heart failure, more common in left-dominant disease. PMC

9. Nocturnal cough/orthopnea – Lying flat worsens breathlessness in LV failure (Carvajal phenotype). PMC

10. Reduced exercise capacity in teens/young adults – Often the first cardiac sign in previously healthy kids with hair/skin clues. Heart Rhythm Journal

11. Sudden cardiac arrest – May be the first presentation in some; underscores the need for early diagnosis and risk assessment. Heart Rhythm Journal

12. Skin fissures, infections – Cracks in thickened skin can be painful and occasionally infected. PMC

13. Family history of similar hair/skin plus heart problems – A powerful diagnostic clue prompting gene testing. Orpha

14. Anxiety from recurrent palpitations/fainting – Common and understandable; part of holistic care. Heart Rhythm Journal

15. Asymptomatic early stages – Some children feel fine for years despite evolving ECG or MRI changes. Heart Rhythm Journal

Diagnostic tests

A) Physical examination

1. General exam and growth check – Doctors look for overall wellbeing and signs of heart failure (leg swelling, enlarged liver) while noting woolly hair and palm/sole skin changes that point toward a cardio-cutaneous syndrome. PMC

2. Skin inspection – Confirms diffuse vs striate keratoderma, helping differentiate Naxos (diffuse) from Carvajal (striate). PMC

3. Cardiac auscultation – May detect gallops or murmurs that suggest a weakened or dilated ventricle. Heart Rhythm Journal

4. Vital signs at rest and after walking – Heart rate, blood pressure, and oxygen levels can show stress responses or heart failure. Heart Rhythm Journal

5. Family screening visit – Examining relatives can reveal the same hair/skin signs or subtle heart findings that support an inherited pattern. Orpha

B) Manual/bedside tests

6. 12-lead ECG – Looks for T-wave inversions, epsilon waves, low voltages, or conduction delay—signals of scarring and conduction block typical of arrhythmogenic cardiomyopathy. lahrs.org

7. Ambulatory rhythm monitoring (Holter/patch) – Records heartbeats over 24–14 days to catch premature beats, nonsustained VT, or dangerous rhythms that come and go. Heart Rhythm Journal

8. Exercise testing (carefully supervised) – Helps uncover exercise-triggered arrhythmias and guides safe-activity advice; testing is tailored because vigorous exertion can be risky. Heart Rhythm Journal

C) Laboratory & pathological tests

9. Genetic testing panel – Searches for variants in JUP, DSP, and other desmosomal genes; a positive result confirms cause, guides family screening, and supports earlier prevention. ScienceDirect+1

10. Cascade testing for relatives – Once a familial variant is known, targeted testing of parents/siblings/children finds who needs ongoing heart checks. Heart Rhythm Journal

11. Cardiac biomarker blood tests (BNP/NT-proBNP, troponin) – Elevations can suggest active injury (“hot phase”) or heart failure strain. PMC

12. Skin or endomyocardial biopsy (selected cases) – Under the microscope, doctors may see fibro-fatty replacement and, with special stains, reduced junction proteins (e.g., plakoglobin), supporting the diagnosis when imaging is unclear. PMC

13. Inflammation/infection workup when indicated – If symptoms resemble myocarditis, targeted labs help separate infection-triggered injury from genetic ACM flares. PMC

D) Electro-diagnostic tests

14. Signal-averaged ECG – Detects tiny, late electrical potentials that indicate slow conduction in scarred tissue, adding weight to a diagnosis of ARVC/ACM. lahrs.org

15. Electrophysiology study (EPS) – In some patients, doctors provoke and map arrhythmias to assess risk or to plan an ablation; used selectively because many patients ultimately need an ICD. Heart Rhythm Journal

16. ICD interrogation (for those with devices) – Reading the implanted defibrillator’s memory shows how often dangerous rhythms occur and whether therapies were delivered. Heart Rhythm Journal

E) Imaging tests

17. Transthoracic echocardiography – First-line ultrasound to assess chamber size, wall motion, and right- vs left-ventricle involvement; repeated over time to track change. Heart Rhythm Journal

18. Cardiac MRI with tissue mapping – The gold standard for detecting fat/fibrosis and regional wall motion abnormalities; in Carvajal syndrome, MRI often shows left-dominant scar. AHA Journals

19. Right/left ventricular angiography (selected centers) – Historical ARVC criteria included angiographic bulges or akinesia; now largely replaced by MRI but still useful in specific scenarios. lahrs.org

20. Chest X-ray – Less specific, but may show heart enlargement or fluid in lungs in advanced disease. Heart Rhythm Journal

Non-pharmacological treatments

1) Exercise restriction (core).
Purpose: cut sudden-death risk. Mechanism: less wall stress → fewer arrhythmia triggers and slower scar growth. Practical: avoid competitive/high-intensity sports; prefer gentle walking, light cycling, stretching; aim for clinician-approved low-intensity minutes/week. Portail Vasculaire+2PMC+2

2) ICD counseling & shared decisions.
Purpose: protect from fatal ventricular arrhythmias. Mechanism: detects/shocks VT/VF. Non-drug but crucial education: discuss benefits, shocks, driving rules, magnets, devices at airports, and pregnancy considerations. Heart Rhythm Journal

3) Family cascade screening & genetic counseling.
Purpose: find affected relatives early; support reproductive choices. Mechanism: test first-degree kin; echo/ECG/MRI as guided. Heart Rhythm Journal

4) Trigger control plan.
Purpose: reduce arrhythmia episodes. Mechanism: avoid stimulants, dehydration, overheating; maintain electrolytes; manage fevers promptly. Heart Rhythm Journal+1

5) Structured symptom diary & remote monitoring.
Purpose: catch patterns early. Mechanism: correlate palpitations with activity; share wearable data (within clinical plan). Heart Rhythm Journal

6) Emergency action plan.
Purpose: fast response to syncope/shock. Mechanism: teach family CPR basics; know local emergency numbers; keep device card. Heart Rhythm Journal

7) Skin care program (PPK).
Purpose: reduce pain/infection. Mechanism: daily emollients, gentle debridement, protect from friction; prompt care of fissures. (Topicals are drugs; the non-drug part is protective footwear, socks, and moisturizing routines.) Medical Journals

8) Psychosocial support.
Purpose: reduce anxiety/depression from shocks/limits. Mechanism: counseling, peer groups, stress-reduction. Heart Rhythm Journal

9) School/sport letters & workplace adjustments.
Purpose: safe participation. Mechanism: written limits; allow breaks; temperature/hydration access. Portail Vasculaire

10) Pregnancy planning.
Purpose: anticipate hemodynamic stress. Mechanism: pre-pregnancy cardio-genetics review; delivery plan in experienced center. Heart Rhythm Journal

11) Infection prevention for skin.
Purpose: avoid fissure infections. Mechanism: daily hygiene, breathable footwear, early wound care. Medical Journals

12) Nutrition basics for heart failure risk.
Purpose: support energy and electrolytes. Mechanism: Mediterranean-style pattern; limit ultra-processed salt/sugar. Heart Rhythm Journal

13) Heat management.
Purpose: cut dehydration/arrhythmia triggers. Mechanism: cool environments, rest in shade, avoid hot-sauna extremes. PMC

14) Alcohol/caffeine moderation.
Purpose: fewer ectopy runs. Mechanism: avoid binge drinking; keep caffeine modest. Heart Rhythm Journal

15) Medication safety list.
Purpose: avoid pro-arrhythmic/QT-prolonging agents. Mechanism: pharmacist review and up-to-date list in wallet/phone. Heart Rhythm Journal

16) Vaccination up to date.
Purpose: reduce fever-related stress (“hot phases”). Mechanism: fewer systemic infections. Heart Rhythm Journal

17) Footwear/orthotics.
Purpose: reduce friction/pressure on keratoderma. Mechanism: cushioned insoles, seamless socks. Medical Journals

18) Regular dental care (esp. Carvajal reports).
Purpose: general health; possible syndrome-linked enamel issues. Mechanism: early dentist involvement. PMC

19) Sun/skin protection.
Purpose: keep skin barrier intact. Mechanism: gentle cleansers, protectants. Medical Journals

20) Clear follow-up schedule
Purpose: spot progression early. Mechanism: periodic ECG/Holter/echo or CMR as per guidelines. Heart Rhythm Journal

---

Drug treatments

Important: Medications must be individualized by a cardiologist/dermatologist; some are off-label in ACM. Medical therapy does not replace an ICD when indicated. JACC

1. Metoprolol (β-blocker, cardio-selective).
   Dose/time: often 25–200 mg/day in divided or extended-release; daily use. Purpose: first-line to reduce ventricular ectopy/VT burden and adrenergic triggers. Mechanism: blocks β-1 receptors → lowers heart rate and stress on scarred myocardium. Side effects: fatigue, dizziness, bradycardia, hypotension. Evidence: guidelines and reviews list β-blockers as foundational therapy in ARVC/ACM. PMC+1

2. Atenolol (β-blocker).
   Dose: 25–100 mg once or twice daily. Purpose/mechanism similar to metoprolol; sometimes preferred per guidance details. Side effects: like above. Oxford Academic

3. Sotalol (Class III with β-blockade).
   Dose: 80–160 mg twice daily (renal-adjusted). Purpose: reduce recurrent VT when β-blocker alone is not enough. Mechanism: prolongs repolarization and provides β-block. Side effects: QT prolongation, torsades risk—requires ECG monitoring. JACC

4. Flecainide (Class Ic; with β-blocker).
   Dose: 50–150 mg twice daily. Purpose: PVC/VT suppression in selected ARVC with preserved function; combine with β-blocker to prevent 1:1 flutter conduction. Side effects: pro-arrhythmia in structural heart disease—specialist use. JACC

5. Amiodarone (Class III).
   Dose: loading then 100–200 mg/day maintenance. Purpose: refractory VT/AF control. Mechanism: multi-channel blockade. Side effects: thyroid, liver, lung, ocular toxicity—requires strict monitoring. JACC

6. Mexiletine (Class Ib).
   Dose: 150–200 mg three times daily. Purpose: adjunct for ventricular ectopy/VT. Side effects: GI upset, tremor; use in experienced centers. Heart Rhythm Journal

7. ACE inhibitors (e.g., Enalapril).
   Dose: titrate to guideline doses. Purpose: ventricular remodeling/heart-failure therapy if LV/RV dysfunction. Mechanism: RAAS blockade. Side effects: cough, hyperkalemia, kidney function changes. Heart Rhythm Journal

8. ARBs (e.g., Losartan).
   Alternative to ACEi; same goals/risks (less cough). Heart Rhythm Journal

9. Mineralocorticoid receptor antagonists (Spironolactone/Eplerenone).
   Dose: 12.5–50 mg/day. Purpose: remodeling/arrhythmia reduction signals in cardiomyopathy with reduced EF. Side effects: hyperkalemia; gynecomastia (spironolactone). Heart Rhythm Journal

10. Loop diuretics (Furosemide).
    Dose individualized. Purpose: symptom relief in congestion. Side effects: electrolyte loss—watch potassium/magnesium. Heart Rhythm Journal

11. Beta-blocker for AF/SVT episodes (e.g., Metoprolol).
    Same class/goal—ventricular rate control if atrial arrhythmias occur. Heart Rhythm Journal

12. Ivabradine (selected heart-failure cases).
    Dose: 2.5–7.5 mg twice daily. Purpose: heart-rate control when β-blockers limited; evidence primarily HF—specialist decision in ACM. Heart Rhythm Journal

13. Digoxin (caution).
    Purpose: rate control in AF with HF; use carefully due to pro-arrhythmic potential in scarred myocardium. Heart Rhythm Journal

14. Topical emollients/urea 10–40% (skin).
    Purpose: soften keratoderma, reduce fissures/pain. Mechanism: keratolysis and hydration. Side effects: local irritation. (Topicals complement non-drug skin routines.) Medical Journals

15. Topical salicylic acid (skin).
    Purpose: keratolytic for thick plaques; careful use to avoid over-irritation. Medical Journals

16. Oral retinoids (Acitretin; dermatology-supervised).
    Dose: weight-based. Purpose: severe PPK refractory to topicals. Side effects: teratogenicity, liver/lipids—strict specialty oversight. Medical Journals

17. Topical antiseptics/antibiotics for fissure infection (short courses).
    Purpose: treat secondary infection. Side effects: local irritation/resistance concerns—short, targeted use. Medical Journals

18. Magnesium repletion (if low).
    Purpose: correct hypomagnesemia that triggers ectopy. Mechanism: stabilizes cardiac ion channels. Side effects: GI upset; avoid in renal failure. Heart Rhythm Journal

19. Potassium repletion (if low).
    Purpose: reduce ventricular ectopy risk. Mechanism: normalizes repolarization. Side effects: hyperkalemia risk—monitor. Heart Rhythm Journal

20. Anticoagulation (selected patients).
    Purpose: stroke prevention if AF/LV thrombus. Mechanism: DOAC/VKA per standard criteria. Risks: bleeding—specialist call. Heart Rhythm Journal

---

Dietary molecular supplements

Note: There is no supplement proven to cure or halt Naxos/Carvajal. The items below are adjuncts to support general heart health or correct deficits—only with clinician approval.

1. Magnesium (if deficient): 200–400 mg/day. Helps stabilize electrical activity; useful only when levels are low. Too much causes diarrhea and can be unsafe with kidney disease. Heart Rhythm Journal

2. Potassium-rich foods / supervised supplements: Dose individualized; aim for normal serum K+. Supports safe repolarization; never self-supplement if on RAAS/MRA without labs. Heart Rhythm Journal

3. Omega-3 (fish oil): 1–2 g/day EPA+DHA may help triglycerides; arrhythmia prevention evidence is mixed—use case-by-case. Heart Rhythm Journal

4. Vitamin D (if deficient): per lab-guided dosing; supports overall health; no direct ACM reversal. Heart Rhythm Journal

5. Coenzyme Q10: 100–200 mg/day sometimes used in cardiomyopathy for symptoms; evidence modest. Heart Rhythm Journal

6. Thiamine (B1) repletion when low (e.g., diuretic use); supports myocardial metabolism. Heart Rhythm Journal

7. Taurine (experimental): limited human data for ventricular ectopy; only with specialist input. Heart Rhythm Journal

8. L-carnitine (if deficient): supports fatty-acid transport; benefit in ACM unproven. Heart Rhythm Journal

9. Selenium (only if deficient): deficiency cardiomyopathy is a different entity, but correcting deficiency is good practice. Heart Rhythm Journal

10. Electrolyte solutions during heat/exertion: individualized sodium/potassium/magnesium balance to avoid triggers. PMC

---

Immunity booster / regenerative / stem-cell” drugs

At present, there are no approved regenerative or stem-cell drugs that fix the desmosomal defect or reverse the scar in Naxos/Carvajal. Research into cell-based therapy and gene-targeted strategies is ongoing in cardiomyopathies, but they remain experimental and should be pursued only in clinical trials. Mechanistically, approaches aim to replace damaged myocardium or correct the faulty gene/protein, but safety, durability, and rhythm-risk effects are not established. Dosage/schedules depend on specific trial protocols and are not routine care. Always discuss trial options with a specialist center. Heart Rhythm Journal

---

Procedures/surgeries

1. Implantable cardioverter-defibrillator (ICD).
   Why: prevents sudden death by terminating VT/VF. Used for secondary prevention (after sustained VT/VF) or primary prevention in high-risk patients by guideline criteria. Heart Rhythm Journal

2. Catheter ablation of VT.
   Why: reduces recurrent VT storms or ICD shocks by targeting scar circuits; does not remove need for ICD when indicated. Heart Rhythm Journal

3. Cardiac resynchronization therapy (CRT) in select HF.
   Why: improves coordination of heartbeats in patients with reduced EF and bundle-branch delay patterns. Heart Rhythm Journal

4. Mechanical circulatory support (LVAD) in advanced HF.
   Why: bridge to transplant or destination therapy when severe LV dysfunction develops (more in Carvajal phenotype). PMC

5. Heart transplantation (end-stage).
   Why: for refractory heart failure or uncontrollable arrhythmias despite maximal care in expert centers. Heart Rhythm Journal

---

Preventions

1. Know your gene status and screen family. Heart Rhythm Journal

2. Avoid high-intensity/competitive sports. Portail Vasculaire

3. Hydrate and manage heat; avoid dehydration. PMC

4. Keep electrolytes normal (especially K+, Mg2+). Heart Rhythm Journal

5. Medication safety list (avoid QT/pro-arrhythmic drugs). Heart Rhythm Journal

6. Prompt fever management and illness care. Heart Rhythm Journal

7. Regular cardiac follow-up with ECG/Holter/echo/CMR. Heart Rhythm Journal

8. Skin protection routines to prevent fissures/infection. Medical Journals

9. Emergency plan & CPR awareness in the household. Heart Rhythm Journal

10. Psychological support to maintain adherence and reduce stress triggers. Heart Rhythm Journal

---

When to see doctors (simple triggers)

• New palpitations, fainting, or chest pounding—urgent evaluation. Heart Rhythm Journal

• Shock from an ICD, multiple shocks, or persistent symptoms—emergency care. Heart Rhythm Journal

• Skin fissures that bleed, ooze, or are very painful—risk of infection; dermatology visit. Medical Journals

• Fever, vomiting, diarrhea, or heat exposure with dizziness—risk of arrhythmia from low electrolytes; seek advice. Heart Rhythm Journal

• Family planning/pregnancy—pre-pregnancy counseling. Heart Rhythm Journal

---

What to eat & what to avoid

1. Do eat: plenty of vegetables, fruits, whole grains, legumes, nuts, and fish (Mediterranean-style) to support overall heart health. Avoid: ultra-processed, high-salt packaged foods that worsen fluid retention. Heart Rhythm Journal

2. Do: steady hydration, especially in heat; avoid: dehydration during activity. PMC

3. Do: foods with natural potassium/magnesium (bananas, leafy greens, beans) if your labs/medications allow; avoid: unsupervised electrolyte supplements. Heart Rhythm Journal

4. Do: moderate caffeine; avoid: energy drinks or stimulant/herbal boosters. Heart Rhythm Journal

5. Do: lean proteins; avoid: heavy alcohol/binges that trigger arrhythmias. Heart Rhythm Journal

6. Do: heart-failure sodium limits if advised; avoid: salty snacks/soups. Heart Rhythm Journal

7. Do: plan electrolytes during hot weather; avoid: sauna/steam extremes. PMC

8. Do: small, regular meals if symptomatic; avoid: large heavy meals before activity. Heart Rhythm Journal

9. Do: safe weight control; avoid: crash diets and stimulant weight-loss products. Heart Rhythm Journal

10. Do: coordinate diet with your cardiology/dermatology team, especially if on RAAS blockers/diuretics. Heart Rhythm Journal

---

Frequently asked questions

1) Is this the same as ARVC?
It’s in the arrhythmogenic cardiomyopathy (ACM) family. Naxos tends to be right-ventricular-dominant (ARVC pattern); Carvajal tends to be left-dominant/biventricular. JACC

2) Why do the hair and skin point to a heart disease?
Because the same desmosome proteins (JUP or DSP) are used in skin/hair and heart muscle. When they’re faulty, both tissues show signs. ScienceDirect

3) How is risk of sudden death managed?
By activity restriction, β-blockers/antiarrhythmics, and ICD when indicated. Ablation helps reduce VT but doesn’t replace an ICD. Heart Rhythm Journal+1

4) Can I play sports?
Guidelines advise no competitive/high-intensity sports; gentle activity under medical advice is usually acceptable. Portail Vasculaire

5) Do all carriers get the disease?
Penetrance varies. Some relatives may carry the variant but have few or no symptoms; regular screening is important. Heart Rhythm Journal

6) Which medicines work best for arrhythmias?
Start with β-blockers; add sotalol, flecainide, or amiodarone in selected cases. Choices depend on your heart’s structure, rhythm type, and side-effect profile. JACC

7) Will drugs replace the ICD?
No. If you meet criteria, ICD is the only proven protection against sudden death. Medicines reduce episodes but are not a substitute. JACC

8) Can topical skin care really help?
Yes. Daily emollients, careful debridement, and protection reduce pain and infection; dermatologists add keratolytics or retinoids if needed. Medical Journals

9) Are there warning drugs to avoid?
Yes—drugs that prolong QT or are pro-arrhythmic. Keep an updated list and check with your pharmacist/clinician. Heart Rhythm Journal

10) What about pregnancy?
Plan with your cardio-genetics team; many women do well with careful monitoring and delivery planning in an experienced center. Heart Rhythm Journal

11) Is this always severe?
Severity varies—even within the same family. Early diagnosis, activity limits, and proper devices/meds greatly improve outcomes. Heart Rhythm Journal

12) Do supplements help?
Only to correct deficiencies or as general heart-healthy support. None cures the gene problem; discuss each item with your clinician. Heart Rhythm Journal

13) How often should I be checked?
Your specialist will set a schedule (often 6–12 months) with ECG/Holter and imaging depending on symptoms and device status. Heart Rhythm Journal

14) Are there clinical trials?
Yes—on ACM risk tools, ablation strategies, device programming, and experimental gene/cell therapies. Ask a tertiary center. Heart Rhythm Journal

15) What’s the single most important lifestyle step?
Avoid high-intensity exercise/competition and follow your personalized plan. This has one of the strongest evidence signals in ACM. Portail Vasculaire+1

 

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 22, 2025.